DETECTING FRONTOTEMPORAL DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS

• US 20140255936A1
• Filed: 09/07/2012
• Published: 09/11/2014
• Est. Priority Date: 09/09/2011
• Status: Abandoned Application

• Current Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Original Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Inventors: Rademakers, Rosa, Hernandez, Mariely DeJesus
• Application Number:
  US14/343,807
• Publication Number:
  US 20140255936A1
• Time in Patent Office: Days
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers

Abstract

This document provides methods and materials for detecting a nucleic acid expansion. For example, methods and materials for detecting the presence of an expanded number (e.g., greater than 30, 50, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, or more copies) of a hexanucleotide repeat (e.g., GGGGCC) in the non-coding region of a C9ORF72 gene are provided.

Claims

1. A method for diagnosing frontotemporal dementia or amyotrophic lateral sclerosis, wherein said method comprises:

(a) detecting the presence of an expanded number of GGGGCC repeats located in a C9ORF72 nucleic acid of a human, and

(b) classifying said human as having frontotemporal dementia or amyotrophic lateral sclerosis based at least in part on the detection of said presence.

2. The method of claim 1, wherein said GGGGCC repeats are located in a non-coding region of said C9ORF72 nucleic acid.

3. The method of claim 1, wherein said method comprises detecting the presence of greater than 100 GGGGCC repeats.

4. The method of claim 1, wherein said method comprises detecting the presence of greater than 500 GGGGCC repeats.

5. The method of claim 1, wherein said detecting step comprises performing a polymerase chain reaction assay.

6. The method of claim 1, wherein said detecting step comprises performing a Southern blot assay.

7. An isolated nucleic acid comprising a C9ORF72 nucleic acid sequence having greater than 50 GGGGCC repeats.

8. An isolated nucleic acid comprising a C9ORF72 nucleic acid sequence having greater than 100 GGGGCC repeats.

9. An isolated nucleic acid molecule for performing a Southern blot analysis, wherein said isolated nucleic acid molecule comprises a C9ORF72 nucleic acid sequence having greater than 20 GGGGCC repeats.

10. A container comprising a population of isolated nucleic acid molecules, wherein said isolated nucleic acid molecules comprise a C9ORF72 nucleic acid sequence having greater than 10 GGGGCC repeats, wherein said population comprises at least five different isolated nucleic acid molecules each with a different number of GGGGCC repeats.

11. The container of claim 10, wherein said isolated nucleic acid molecules comprise a fluorescent label.